We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.
Interneuron activity suggests that there’s more to the story of seizure onset
Cutting-edge imaging, predictive modeling and gene therapy combine for a new direction in neurodegenerative disease research
Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.
Could activated T cells play a major role in driving neurodegeneration in glaucoma?
For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality
A simple yet accurate model could help streamline ROP screening
Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience
Researchers identified the cell types associated with schizophrenia mutations
With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.